Genialis, Inc. Press Releases

• Published on November 8, 2024 - 14:00 GMT

  Genialis Highlights Potential of Xerna TME Panel as a Predictive Biomarker in Poster at SITC 39th Annual Meeting

  With a new partnership with India-based 4baseCare, Genialis addresses the gap in data representation to ensure its AI/ML models work in more diverse populations HOUSTON, TX, UNITED STATES, November 8, 2024 /⁨EINPresswire.com⁩/ -- Genialis, the RNA …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on September 4, 2024 - 13:00 GMT

  Genialis Named Finalist for Biotech Innovation Award at Biotech Week Boston

  Company recognized for advances in RNA- and AI-based diagnostic algorithms; will present new advancements at key industry conferences in September BOSTON, MA, UNITED STATES, September 4, 2024 /⁨EINPresswire.com⁩/ -- Genialis, the RNA biomarker company, …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on July 24, 2024 - 01:00 GMT

  RNA Biomarker Company Genialis Attends BIO ASIA to Grow Collaborations in Taiwan

  Will expand partnerships and presence across Asia as it continues to bridge the global patient data gap to personalize medicine for all cancer patients TAPEI, TAIWAN, July 24, 2024 /⁨EINPresswire.com⁩/ -- Genialis, the RNA-biomarker company, will attend …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on April 3, 2024 - 13:00 GMT

  

  Genialis Enlists Two New Partners as It Assembles World’s Most Ethno-Geographically Diverse Cancer Data Sets

  The addition of data from Sidra Medicine and Sapien Biosciences ensures AI models reflect real-world patients, improving accuracy and clinical utility BOSTON, MA, UNITED STATES, April 3, 2024 /⁨EINPresswire.com⁩/ -- Genialis, the RNA-biomarker company, …

  Distribution channels: Banking, Finance & Investment Industry, Education ...
• Published on September 27, 2023 - 14:14 GMT

  

  Genialis Presents ResponderID KRAS, a Biomarker Framework for Predicting Patient Response

  Genialis points ResponderID, its innovative biomarker framework combining machine learning and RNA-sequencing, at the challenge of KRAS inhibition BOSTON, MA, USA, September 27, 2023 /⁨EINPresswire.com⁩/ -- Genialis, the RNA-biomarker company, today …

  Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...
• Published on August 29, 2023 - 12:00 GMT

  

  Genialis Maintains ISO 27001 Information Security Certification for Sixth Year

  With another successful passing of the ISO/IEC 27001 external audit, Genialis redoubles its commitment to data confidentiality, integrity, and availability BOSTON, UNITED STATES, August 29, 2023 /⁨EINPresswire.com⁩/ -- Genialis, the RNA-biomarker company, …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on August 2, 2023 - 16:06 GMT

  Genialis and BioLab Win Best Regular Paper at the 21st International Conference of Artificial Intelligence in Medicine

  AIME 2023 Marco Ramoni Award-Winning Paper Describes a New Method for Survival Analysis and Gene Ranking BOSTON, MA, USA, August 2, 2023 /⁨EINPresswire.com⁩/ -- Genialis, a computational precision medicine company unraveling complex biology to find new …

  Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...